For decades, Huntington’s disease was viewed almost entirely through the lens of genetics and neurology. A person either carried the mutation or they did not, symptoms emerged, progression unfolded, and treatment options were largely limited to symptom management and supportive care. The genetics remain real and undeniable. Huntington’s disease is caused by a mutation in the huntingtin gene which leads to the production of an abnormal protein that gradually becomes toxic to neurons, particularly within areas of the brain responsible for movement, emotional regulation, cognition, motivation, behaviour, and executive functioning. What has changed significantly over recent years is not the existence of the gene itself, but our understanding of the environment in which neurodegeneration develops and the wider physiological systems involved in how the nervous system copes over time.

The older model of medicine often treated the brain almost as though it functioned separately from the rest of the body. Modern neuroscience increasingly suggests something very different. The brain is deeply interconnected with immune signalling, mitochondrial function, inflammatory pathways, gut health, blood sugar regulation, sleep architecture, detoxification systems, nutrient sufficiency, stress chemistry, and the wider physiology of the nervous system itself. This is one of the reasons neurodegenerative illnesses are becoming so interesting from a functional and systems medicine perspective. Huntington’s disease is often recognised by the involuntary movements associated with the condition, known as chorea, but neurological changes frequently begin long before severe physical symptoms emerge. Anxiety, depression, sleep disturbance, emotional dysregulation, cognitive changes, impulsivity, fatigue, altered motivation, and nervous system overwhelm can all appear years earlier, sometimes long before a formal diagnosis is even made.

Underneath those symptoms are multiple overlapping physiological processes which appear to interact continuously with one another. Research increasingly points towards mitochondrial dysfunction, oxidative stress, glutamate excitotoxicity, neuroinflammation, impaired cellular repair systems, altered energy metabolism, and dysfunction within the brain’s communication pathways. From a functional medicine perspective, this raises important questions about the terrain surrounding the nervous system itself. How resilient are the mitochondria responsible for producing energy inside vulnerable neurons? What is happening with inflammatory signalling throughout the body? Is chronic stress physiology placing additional strain on an already vulnerable nervous system? Are detoxification pathways functioning efficiently? Is the microbiome contributing to inflammatory load? Are nutrient deficiencies impairing repair and recovery mechanisms? What role may sleep disruption, blood sugar instability, trauma physiology, chronic cortisol elevation, or environmental toxic burden play within the wider picture of neurological resilience?

None of these questions deny the reality of the gene mutation. They simply acknowledge that genes operate within biological systems rather than in isolation. One of the most important shifts in medicine over recent years has been the growing understanding that genes are not always simple fixed destinies unfolding identically in every individual. The mutation itself may exist, but the terrain surrounding neuronal survival, inflammation, repair capacity, oxidative burden, detoxification efficiency, mitochondrial resilience, and nervous system regulation may still influence how the body copes over time. This is where modern systems biology becomes particularly important because the nervous system is metabolically demanding tissue. Neurons require enormous amounts of energy to regulate signalling, maintain repair systems, clear damaged proteins, protect themselves against oxidative stress, and maintain stable communication pathways throughout the brain and body. In Huntington’s disease, many of these systems appear to become impaired long before advanced degeneration occurs.

Researchers are now exploring treatments designed to directly reduce production of the toxic huntingtin protein itself through gene-silencing therapies. This represents an extraordinary development within neurology because medicine is beginning to move beyond merely suppressing symptoms and towards attempting to alter the disease process itself. Alongside these developments, there is increasing interest in broader physiological support aimed at protecting neuronal resilience as effectively as possible. This may include exploring mitochondrial support, antioxidant systems, glutathione pathways, omega-3 fatty acids, magnesium status, methylation pathways, inflammatory regulation, microbiome health, restorative sleep, blood sugar stability, movement, neuroplasticity, and reducing chronic inflammatory burden within the body. Increasingly, medicine is recognising that the nervous system does not function independently of the wider physiology surrounding it.

Nervous system regulation may also become highly relevant within neurodegenerative illness because chronic stress chemistry influences inflammatory pathways, mitochondrial efficiency, immune signalling, glutamate activity, hormonal balance, sleep quality, and cellular repair mechanisms throughout the body. Long-term hypervigilance, unresolved trauma, chronic overload, and sustained cortisol elevation may place additional strain on systems already attempting to compensate for neurological vulnerability. This is one of the reasons functional medicine increasingly looks beyond a diagnosis label alone. Rather than seeing the brain as disconnected from the rest of physiology, a systems approach asks how all of the networks within the body are interacting together continuously. Genetics, environment, toxic load, hormones, inflammation, nutrition, microbiome signalling, methylation, stress physiology, and nervous system regulation all influence one another in ways which are complex, dynamic, and highly individual.

Importantly, this is not about claiming that Huntington’s disease can be cured naturally. The genetic mutation is real and serious. However, there is a major difference between claiming to reverse a disease and asking how we might better support resilience, function, quality of life, and nervous system stability within the person living with that condition. The future of neurodegenerative care may ultimately become increasingly integrative, with conventional neurology, gene-targeted therapies, rehabilitation, nutritional medicine, metabolic support, nervous system regulation, trauma-informed approaches, and systems biology all having important roles to play together. As neuroscience evolves, medicine is gradually moving away from viewing the brain as an isolated organ and towards understanding it as part of a deeply interconnected living system. Huntington’s disease may be one of the clearest examples yet of why that wider perspective matters.